Clinical trial
Dapagliflozin Effects on Epicardial Fat
NCT02235298
Study timeline
Study start (actual)2015-09-01Date precision: month
Registry last updated2021-02-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
DapagliflozinDRUG · verified · RxNorm: dapagliflozin
MetforminDRUG · verified · RxNorm: metformin
PlaceboDRUG
Sponsors & collaborators
University of Miamilead sponsor
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02235298 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.